Mirion Technologies, which is backed by Charterhouse, has acquired Capintec Inc, a provider of calibration and measurement technologies for nuclear medicine applications. No financial terms were disclosed.
On July 9, 2019, Mirion Technologies (“Mirion”) acquired Capintec, Inc. (“Capintec”), a leading supplier of calibration and measurement technologies for nuclear medicine applications. The acquisition of Capintec is consistent with Mirion’s inorganic strategic expansion plan, which is focused on enhancing Mirion’s portfolio of industry leading technology offerings across a range of core and adjacent end markets.
To fund its expansion plan, Mirion closed a $34 million add-on to its term loan B on July 8, 2019 with Morgan Stanley Senior Funding, Inc. serving as lead arranger. The add-on financing was well received by lenders as it priced at the tight end of initial price talk and was oversubscribed. Consistent with management’s strategic roadmap, Mirion has engaged financial advisors to assist in evaluating a range of strategic options for the company.
Backed by Charterhouse Capital Partners, Mirion is a leading provider of detection, measurement, analysis and monitoring solutions to the nuclear, defense, medical and research end markets. Since being acquired by Charterhouse in 2015, Mirion has been an active acquiror beginning with its transformational acquisition of Canberra in 2016, followed by multiple smaller “bolt-on” deals. Together, these acquisitions have materially enhanced Mirion’s global reach with a broad portfolio of product offerings. Mirion has facilities in Europe, Asia, and North America and is headquartered in San Ramon, California. For additional information, please visit: www.mirion.com
Charterhouse is one of the longest established private equity firms operating in Europe. The firm generally invests in companies headquartered in Western Europe and works closely with incumbent management teams, backing them and providing active support to drive growth. Charterhouse pursues a highly selective investment approach, partnering with a small number of high-quality companies. Transaction values range from €200mn to €1.5bn and are focused in the services, healthcare, industrials and consumer sectors. Charterhouse is based in London and has a deep bench of experienced investment professionals. Charterhouse has over €4bn of assets under management. For additional information, please visit: www.charterhouse.co.uk